<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-421
Date of Submission: 2024-11-30

This report was submitted by a Nurse from Singh-Sherman Medical Center concerning patient ANON-PX-6075. The subject is an adult male with a significant medical history including migraines, type 2 diabetes. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Ibuprofen administered via the Oral route at a dosage of 140mg, initiated on 2024-10-22 for Pain and inflammation with the course ongoing; Gabapentin (Anticonvulsant) administered via the Intravenous route at a dosage of 317mg, initiated on 2024-10-22 for Neuropathic pain with the course ongoing.

On approximately 2024-11-07, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Stevens-Johnson syndrome. The Nausea was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Stevens-Johnson syndrome was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 1 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Other go boy. Receive guy include ten water personal not.</data>
report_id: ADR-2024-421
report_date: '2024-11-30'
patient_details:
  patient_id: ANON-PX-6075
  gender: Male
  relevant_history:
  - migraines
  - type 2 diabetes
suspected_drugs:
- drug_name: Ibuprofen
  dosage: 140mg
  route_of_administration: Oral
  start_date: '2024-10-22'
  indication_for_use: Pain and inflammation
- drug_name: Gabapentin
  dosage: 317mg
  route_of_administration: Intravenous
  start_date: '2024-10-22'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2024-11-07'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2024-11-07'
  severity: Mild
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 1
reporting_facility: Singh-Sherman Medical Center
reporter_type: Nurse
notes: Other go boy. Receive guy include ten water personal not.
